Journal list Promote Sponsor
verified SJR 0,633 · Q2 • database Scopus / SJR & Web of Science indexed
Diagnostic Microbiology and Infectious Disease
United States · Elsevier Inc.
workspace_premium Q2 — Medicine (miscellaneous) lock Subscription

Diagnostic Microbiology and Infectious Disease

Diagnostic Microbiology and Infectious Disease is a journal indexed in SJR in Medicine (miscellaneous) and Infectious Diseases with an H index of 106. It has an SJR impact factor of 0,633 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,633.

Diagnostic Microbiology and Infectious Disease focuses its scope in these topics and keywords: staphylococcus, detection, patients, activity, clinical, isolates, aureus, time, infections, lyme, ...

ISSN: 0732-8893
Publisher: Elsevier Inc.
Category: Medicine (miscellaneous)
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,633 Q2
H-index 106
Acceptance rate pie_chart
24% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,633

H-index

106

Docs (year)

362

Docs 3y

563

Total refs

10403

Cites 3y

1060

Citable 3y

547

Cites/Doc 2y

1.88

Ref/Doc

28.74

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cefotaxime twice daily versus ceftriaxone once daily

View more

Whipple's disease presenting as chronoc wastage and abdominal lymphadenopathy

View more

Dissemination of pulmonary blastomycosis after thoracotomy

View more

Detection of EspB using reversed passive latex agglutination: application to determination of enteropathogenic Escherichia coli

View more

Cross-resistance phenotypes of fluconazole-resistant Candida species: Results with 655 clinical isolates with different methods

View more

Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin)

View more

Correlation of aztreonam susceptibility results obtained with the MicroScan® system to reference tests

View more

Comparative in vitro activity of furopenem against aerobic bacteria isolated from pediatric patients

View more

Clinical Studies of Cefpirome in the Treatment of Urinary Tract Infections Caused by Enterococcus faecalis

View more

Clinical perspectives on the management of community-acquired pneumonia

View more

Ciprofloxacin in treatment of nosocomial meningitis in neonates and in infants: report of 12 cases and review

View more

Cellulitis: evaluation of possible predisposing factors in hospitalized patients

View more
SHOW MORE ARTICLES

Cefpirome Versus Ceftazidime as Empirical Sepsis Treatment

View more

Activity of a broad-spectrum cephalosporin (Ro 48-8391) alone and in combination with two novel beta-lactamase inhibitors (Ro 48-5545 and Ro 48-8724)

View more

Cefotaxime for treatment of neonatal sepsis and meningitis

View more

Cefotaxime for the 1990s

View more

Cefotaxime

View more

Cefepime versus ceftazidime for the treatment of serious bacterial infections

View more

Bactericidal activity of the fluoroquinolone DU-6859a alone and in combination with other antimicrobial agents against multiresistant enterococci

View more

Assessment of the first commercial multiplex PCR kit (ParaGENIE Crypto-Micro Real-Time PCR) for the detection of Cryptosporidium spp., Enterocytozoon bieneusi, and Encephalitozoon intestinalis from fecal samples

View more

Antimicrobial susceptibility of clinical isolates of Acinetobacter baumannii

View more

Antimicrobial characteristics of quinupristin/dalfopristin (Synercid® at 30:70 ratio) compared to alternative ratios for in vitro testing

View more

Antibacterial effect of chlorhexidine on bacteria adsorbed onto experimental dental plaque

View more

An unusual site of chigger bite in a patient with scrub typhus

View more

FAQs